Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Two novel series of HDAC inhibitors discovered at Beacon

Jan. 12, 2004

Chemokine Therapeutics files for U.S. orphan drug designation for CTCE-9908

Jan. 9, 2004

U.S. enrollment commences for phase II SDX-105 study

Jan. 9, 2004

Enrollment stopped in phase II of Velcade for metastatic colorectal cancer

Jan. 9, 2004

Update on Generex technologies

Jan. 9, 2004

Bayer scientists claim new pyrimidine-based antiproliferative agents

Jan. 9, 2004

Novel FAP-activated prodrugs with utility in cancer therapy

Jan. 9, 2004

Novel chemopreventive and chemotherapeutic agents identified at the U. of Mississippi

Jan. 8, 2004

French scientists describe new potentiators of antiplasmodial and antitumor agents

Jan. 8, 2004

New antitumor azoles in early development at Sankyo

Jan. 7, 2004

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...